How Obamacare, Medicare And ‘Medicare For All’ Muddy The Campaign Trail
(By Shefali Luthra for Kaiser Health News) The health care debate has Democrats on Capitol Hill and the presidential campaign
Read moreElections – Healthcare issues
For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It
(By Shefali Luthra for Kaiser Health News) Democrats with 2020 presidential aspirations are courting the party’s increasingly influential progressive wing
Read moreDrug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
(By Shefali Luthra for Kaiser Health News) The next presidential primary contests are more than a year away. But presumed
Read moreWith new drug pricing legislation, Grassley and Wyden hint at the next steps for a powerful Senate committee
(By Ike Swetlitz for STAT) WASHINGTON — A powerful, bipartisan pair of lawmakers introduced new legislation Tuesday that would give
Read moreAfter successes at the ballot box, this drug pricing advocacy group is setting its sights on results
(By Lev Facher for STAT) WASHINGTON — The advocacy group Patients for Affordable Drugs had a near-perfect night at the
Read moreWhat political party do senior voters trust on health care
In a recent poll, the Democrat’s emphasis on health care may give them a modest, but not a decisive, advantage
Read moreQuick: What’s The Difference Between Medicare-For-All and Single-Payer?
(By Samantha Young for Kaiser Health News) MODESTO, Calif. — Betsy Foster and Doug Dillon are devotees of Josh Harder.
Read moreThis group of lawmakers has a new plan to bring down insulin prices, and it takes clear aim at drug makers
(By Nicholas Florko for STAT) WASHINGTON — A bipartisan group of more than 290 lawmakers is throwing its support behind
Read morePharma’s ‘come-to-Jesus moment’: The industry braces for a Pelosi speakership and Democrats’ drug pricing agenda
(By Lev Facher for STAT) WASHINGTON — Nancy Pelosi marched into PhRMA’s offices this July with the law on her
Read moreCOMPARISON OF U.S. AND INTERNATIONAL PRICES FOR TOP MEDICARE PART B DRUGS BY TOTAL EXPENDITURES
(Source – aspe.hhs.gov) The prices charged by drug manufacturers to wholesalers and distributors (commonly referred to as exmanufacturers prices) in
Read more